Call for papers: Connective tissue disease-associated interstitial lung disease
BMC Pulmonary Medicine is calling for submissions to our Collection on connective tissue disease-associated interstitial lung disease.
Interstitial Lung Disease (ILD) is a common manifestation of several systemic autoimmune connective tissue diseases (CTDs). While ILD can manifest with all CTDs, it most commonly affects individuals with rheumatoid arthritis (RA, 10-30%), systemic sclerosis (SSc, 40-80%), and idiopathic inflammatory myopathy (IIM, 40%). In some patients, ILD could also be the initial or only manifestation of an underlying CTD and the research classification “interstitial pneumonia with autoimmune features (IPAF)” was recently proposed to identify these patients. ILD poses a significant burden, contributing to morbidity and mortality among CTD patients. Given the complexity in the diagnosis and treatment of CTD-related ILD, a multidisciplinary approach to management is crucial.
Over the years, advances in research have improved our understanding and management of CTD-related ILD. However, there are still significant gaps in our knowledge. With the emergence of new therapies for this patient population, there is an increased need to identify clinical characteristics and biomarkers that could predict those who are likely to develop ILD and/or have progressive disease. There is also a continued need to understand additional mechanistic pathways that lead to ILD, in order to develop novel therapies.
For this research topic collection, BMC Pulmonary Medicine invites basic and clinical research papers that could enhance our understanding of CTD-associated ILD and contribute to the advancement of patient care.
Topics of interest for this Collection include but are not limited to:
• Mechanisms and genetics associated with CTD-ILD
• Epidemiology of CTD-ILD: prevalence, mortality, hospitalizations
• Early diagnosis, risk predictors and biomarkers that could predict development and prognosis of CTD-ILD
• Novel therapies for CTD-ILD
• Barriers/limitations to timely care
• Multidisciplinary approach to diagnosis and treatment, and other treatment models
Meet the Guest Editors
Bruno Guedes Baldi: University of Sao Paulo Medical School, Brazil
Dr Bruno Guedes Baldi is a Pulmonologist. He is the Medical Assistant of the Pulmonary Division, Heart Institute (InCor) at the University of Sao Paulo Medical School, Sao Paulo, Brazil. His expertise is in interstitial and rare lung diseases, with a hundred articles published. He has served as an editor, including Associate Editor of Frontiers in Medicine and BMC Pulmonary Medicine, as well as Editor-in-Chief of the Jornal Brasileiro de Pneumologia from 2019 to 2022
Niranjan Jeganathan: Loma Linda University Health System School of Medicine, US
Dr Niranjan Jeganathan is a pulmonologist with a special interest in interstitial lung diseases (ILD). He is the Director of the ILD Center at Loma Linda University (California) which is a Pulmonary Fibrosis Foundation Care Center. His research interest within ILD is in understanding the epidemiology of ILD including Connective Tissue Diseases-Related ILD. He has been an editor for other research collections related to ILD. In addition, he has reviewed numerous ILD articles for many different journals.
Jin Woo Song: University of Ulsan College of Medicine, South Korea
Dr Jin Woo Song is Professor in the Department of Pulmonary and Critical Care Medicine at the University of Ulsan College of Medicine, South Korea. He is currently Director of the ILD Program at Asan Medical Center in Seoul, South Korea. His academic interests include the effects of air pollution on clinical outcomes in ILD, metabolic changes in ILD and biomarkers in ILD.
Submission Guidelines
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Connective tissue disease-associated interstitial lung disease" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Submission Status: Open | Submission Deadline: 8 April 2024
Follow the Topic
-
BMC Pulmonary Medicine
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With collections, you can get published faster and increase your visibility.
Aging and lung disease
BMC Pulmonary Medicine calls for submissions to our Collection on Aging and lung disease. The aging process is associated with physiological changes in the respiratory system, leading to an increased susceptibility to lung diseases such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, and lung cancer. Additionally, age-related alterations in the immune system, including inflammaging and cellular senescence, contribute to the pathogenesis of lung diseases. Understanding the complex interplay between aging and lung disease is crucial for developing effective strategies for prevention, diagnosis, and management.
Continued advancement of our collective understanding in this area is essential for addressing the growing burden of lung diseases in aging populations. Recent advances have elucidated the molecular mechanisms underlying inflammaging and senescence in the context of lung disease, paving the way for the development of novel therapeutic approaches targeting these processes. Furthermore, research has highlighted the impact of aging on the susceptibility to respiratory infections and the development of lung cancer, emphasizing the need for tailored interventions for older adults.
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being and SDG 10: Reduced Inequalities. Topics might include but are not limited to:
• Inflammaging and its impact on lung health
• Senolytics and their potential in treating age-related lung diseases
• Age-related changes in the lung microenvironment
• Respiratory infections in aging populations
• Lung cancer in the context of aging
Publishing Model: Open Access
Deadline: Jul 08, 2025
Chronic cough: epidemiology, pathophysiology, diagnosis and management
BMC Pulmonary Medicine calls for submissions to our Collection on cough sensitivity and chronic cough. Chronic cough remains a long-lasting and burdensome condition affecting a significant portion of the global population across all ages. Excessive coughing can significantly affect physical and mental health - it can disrupt daily life, leading to sleep disturbances, fatigue, and diminished productivity. The underlying conditions triggering chronic cough, if untreated, may escalate, potentially causing complications and compromising respiratory function. Multiple mechanisms and aetiologies may underlie chronic cough, making the disorder challenging to treat.
Recent advances are improving our understanding of the mechanisms contributing to cough hypersensitivity and excessing coughing, paving the way for new therapies. However, more research is needed to improve patients' lives and translate novel discoveries to the clinic.
In alignment with the Sustainable Development Goal 3: Good Health & Wellbeing, this Collection seeks to delve into the intricacies of chronic cough, addressing a broad spectrum of topics, including but not limited to:
• Epidemiological studies on cough hypersensitivity and chronic cough
• The mechanisms/pathophysiology of cough hypersensitivity and chronic cough
• Diagnosis, screening and prevention
• Management strategies
• Psychosocial impact of chronic cough
• Emerging research avenues for chronic cough management and treatment (e.g. personalized medicine)
Publishing Model: Open Access
Deadline: Mar 27, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in